Ryan Allway April 1st, 2021 Psychedelics, Top News San Diego, California–(Newsfile Corp. – April 1, 2021) – Tryp Therapeutics Inc. (CSE: TRYP) (“Tryp” or the “Company“), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, is pleased to announce that it has appointed Greg... Read more
Salvatore Milia Appointed to CLC Board of Directors, Assigned to Lead R&D Efforts for Production of TAAT™
Hemp March 26, 2021
Ryan Allway March 26th, 2021 VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to announce that Salvatore Milia has been appointed to the Company’s Board of Directors, effective immediately. In a... Read more
Liam Harrison March 25th, 2021 Psychedelics, Top News Alexander Flemming’s accidental discovery of penicillin exists in stark contrast to the typical processes and timelines associated with drug discovery. Most drugs, on the contrary, are not accidentally discovered and are developed over long timelines ranging from 5 to 15 years,... Read more
Ryan Allway March 19th, 2021 Psychedelics, Top News TORONTO, March 19, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce... Read more
Under the partnership with ERO, the Company will leverage its statewide distribution infrastructure to serve as the exclusive distributor of ERO’s diverse line of finished goods across multiple product categories—including cannabis vape cartridges, concentrates, extracts, pre-rolls, and flower—to Highlanders’ rapidly growing customer base of over 200 licensed retailers throughout California.... Read more
To Lead Commercialization Efforts, Renowned Agriculture Commodities Trader Rob Jones is Named President of Christina Lake Cannabis
March 18, 2021
Regarding his promotion to the position of President of CLC, Rob Jones commented, “Cannabis and its derivatives are rapidly gaining popularity worldwide, which I believe can be attributed to a combination of greater acceptance as well as innovations in both cultivation techniques and end-user applications. Commodity supply chains can... Read more
TORONTO, ON / ACCESSWIRE / March 18, 2021 / Novamind Inc. (CSE: NM, OTC: NVMDF, FSE: HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is pleased to announce that its wholly-owned subsidiary, Cedar Clinical Research (“CCR”) has been selected as a key research site for a... Read more
Tryp Therapeutics Announces Provisional Patent Filing For Improved Administration of Psychedelics
March 18, 2021
La Jolla, California–(Newsfile Corp. – March 18, 2021) – Tryp Therapeutics (CSE: TRYP), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today that it has submitted a provisional patent (US 63/161,070) to improve how psychedelics are administered across a broad range of... Read more
CORRECTION: FinCanna Capital Corp. Clarifies Closing Proceeds of Non-Brokered Private Placement
March 11, 2021
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Ryan Allway March 5th, 2021 News, Top News Cannabis stocks rebounded nearly 700% from their all-time lows in March 2020 to their highs in February, driven by a combination of robust fundamentals and increasing retail investor interest in the space. Following in the footsteps of the cannabis industry, psychedelics... Read more
